Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy

Cancer is one of the most frequently diagnosed diseases, and despite the continuous efforts in searching for new and more effective treatments, its morbidity and mortality remain a significant health problem worldwide. Calorie restriction, a dietary manipulation that consists in a reduction of the calorie intake, is gaining attention as a potential adjuvant intervention for preventing and/or fighting cancer. Several forms of energy reduction intake, which includes caloric restriction tout-court, dietary restrictions, and intermittent fasting, are being explored for their ability to prevent or slow down cancer progression. Additionally, another anti-cancer approach being under investigation relies on the use of nutraceuticals known as “Caloric Restriction Mimetics” that can provide caloric restriction-mediated benefits without subjecting the patients to a strict diet. Preclinical in vitro and in vivo studies consistently show that diet modifiers reducing the calorie have impact on tumor microenvironment and cancer metabolism, resulting in reduced growth and progression of cancer. Preliminary clinical studies show that patients subjected to a reduced nutrient/energy intake experience improved outcomes from chemo- and radiotherapy while better tolerating the side effects. Here, we review the state of the art on the therapeutic potential of calorie restriction and of caloric restriction mimetics in preventing or retarding tumor development by modulating a subset of cellular processes. The most recent clinical progresses with caloric restriction mimetics in the clinical practice are also discussed.

[1]  Da-ping Yu,et al.  Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways , 2021, Frontiers in Cell and Developmental Biology.

[2]  Andrea Esposito,et al.  Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy , 2021, Cells.

[3]  R. de Cabo,et al.  Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition , 2021, Nature Communications.

[4]  Dudley Lamming,et al.  Molecular mechanisms of dietary restriction promoting health and longevity , 2021, Nature reviews. Molecular cell biology.

[5]  D. Klionsky,et al.  A Perspective on the Role of Autophagy in Cancer. , 2021, Biochimica et biophysica acta. Molecular basis of disease.

[6]  V. Longo,et al.  Intermittent and Periodic Fasting, Hormones, and Cancer Prevention , 2021, Cancers.

[7]  L. Fontana,et al.  Intermittent fasting in the prevention and treatment of cancer , 2021, CA: a cancer journal for clinicians.

[8]  A. Jayedi,et al.  The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. , 2021, The American journal of clinical nutrition.

[9]  J. Janssen Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer , 2021, International journal of molecular sciences.

[10]  M. Waly,et al.  Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities , 2021, Current issues in molecular biology.

[11]  A. E. Musa,et al.  Boosting immune system against cancer by resveratrol , 2021, Phytotherapy research : PTR.

[12]  N. Simone,et al.  Caloric restriction impairs regulatory T-cells within the tumor microenvironment after radiation and primes effector T-cells. , 2021, International journal of radiation oncology, biology, physics.

[13]  K. Dev,et al.  Autophagy Paradox of Cancer: Role, Regulation, and Duality , 2021, Oxidative medicine and cellular longevity.

[14]  F. Trotta,et al.  Cyclodextrin nanosponge for the GSH-mediated delivery of Resveratrol in human cancer cells , 2021, Nanotheranostics.

[15]  T. Lihoreau,et al.  Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  A. Krześlak,et al.  Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy , 2021, Cancer control : journal of the Moffitt Cancer Center.

[17]  D. Ojcius,et al.  Recent advances in the field of caloric restriction mimetics and anti-aging molecules , 2020, Ageing Research Reviews.

[18]  C. Isidoro,et al.  How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer , 2020, Frontiers in Oncology.

[19]  E. Ibrahim,et al.  Energy and caloric restriction, and fasting and cancer: a narrative review , 2020, Supportive Care in Cancer.

[20]  K. Koo,et al.  Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review , 2020, International journal of molecular sciences.

[21]  S. Khalesi,et al.  A review of fasting effects on the response of cancer to chemotherapy. , 2020, Clinical nutrition.

[22]  B. Majello,et al.  Autophagy Roles in Genome Maintenance , 2020, Cancers.

[23]  T. Saliev,et al.  Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research , 2020, Nutrients.

[24]  R. Klement Addressing the controversial role of ketogenic diets in cancer treatment , 2020, Expert review of anticancer therapy.

[25]  C. Isidoro,et al.  Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved , 2020, Journal of traditional and complementary medicine.

[26]  D. Sabatini,et al.  Dietary modifications for enhanced cancer therapy , 2020, Nature.

[27]  A. Meehan,et al.  Cancer and older adult patient care , 2020, Hospital practice.

[28]  J. DeGregori,et al.  Cancer as a disease of old age: changing mutational and microenvironmental landscapes , 2020, British Journal of Cancer.

[29]  Gowthamarajan Kuppusamy,et al.  Metformin in breast cancer: preclinical and clinical evidence. , 2020, Current problems in cancer.

[30]  R. Sweeney,et al.  Ketogenic diets in medical oncology: a systematic review with focus on clinical outcomes , 2020, Medical Oncology.

[31]  Everolimus , 2020, Reactions Weekly.

[32]  M. Sarker,et al.  Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects , 2019, Journal of Experimental & Clinical Cancer Research.

[33]  F. Abas,et al.  Mechanistic Understanding of Curcumin’s Therapeutic Effects in Lung Cancer , 2019, Nutrients.

[34]  M. V. Vander Heiden,et al.  A framework for examining how diet impacts tumour metabolism , 2019, Nature Reviews Cancer.

[35]  Rajeev K. Singla,et al.  Natural Polyphenols: Chemical Classification, Definition of Classes, Subcategories, and Structures. , 2019, Journal of AOAC International.

[36]  E. Tagliabue,et al.  Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases , 2019, Journal of immunology research.

[37]  H. Pijl,et al.  Effects of short-term fasting on cancer treatment , 2019, Journal of Experimental & Clinical Cancer Research.

[38]  Carlo Follo,et al.  Amino acid response by Halofuginone in Cancer cells triggers autophagy through proteasome degradation of mTOR , 2019, Cell Communication and Signaling.

[39]  G. Kroemer,et al.  Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential. , 2019, Cell metabolism.

[40]  Yiyi Lu,et al.  The signaling pathways that mediate the anti-cancer effects of caloric restriction. , 2019, Pharmacological research.

[41]  Mhd Anas Tomeh,et al.  A Review of Curcumin and Its Derivatives as Anticancer Agents , 2019, International journal of molecular sciences.

[42]  Subash C. Gupta,et al.  Health benefits of resveratrol: Evidence from clinical studies , 2019, Medicinal research reviews.

[43]  Y. Song,et al.  Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer , 2019, International journal of molecular sciences.

[44]  Harald W. Platta,et al.  mTOR: A Cellular Regulator Interface in Health and Disease , 2019, Cells.

[45]  G. Barreto,et al.  The effect of fasting or calorie restriction on autophagy induction: A review of the literature , 2018, Ageing Research Reviews.

[46]  O. Kepp,et al.  Spermidine reduces cancer-related mortality in humans , 2018, Autophagy.

[47]  C. Isidoro,et al.  Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. , 2018, Cancer letters.

[48]  Shankargouda Patil,et al.  Autophagy in health and disease: A comprehensive review. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  R. Bamezai,et al.  Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition , 2018, Scientific Reports.

[50]  K. Aquilano,et al.  Pushing the Limits of Cancer Therapy: The Nutrient Game , 2018, Front. Oncol..

[51]  A. Levy,et al.  Metformin for non-small cell lung cancer patients: Opportunities and pitfalls. , 2018, Critical reviews in oncology/hematology.

[52]  P. Pedrazzoli,et al.  To fast, or not to fast before chemotherapy, that is the question , 2018, BMC Cancer.

[53]  Guido Kroemer,et al.  Spermidine in health and disease , 2018, Science.

[54]  Carlo Follo,et al.  The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells , 2017, Molecular carcinogenesis.

[55]  Alexander Aliper,et al.  Towards natural mimetics of metformin and rapamycin , 2017, Aging.

[56]  Arch G Mainous,et al.  Flipping the Metabolic Switch: Understanding and Applying Health Benefits of Fasting , 2017, Obesity.

[57]  M. Okaniwa,et al.  Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy , 2017, PloS one.

[58]  Mingmei Zhou,et al.  Combination treatment with quercetin and resveratrol attenuates high fat diet-induced obesity and associated inflammation in rats via the AMPKα1/SIRT1 signaling pathway , 2017, Experimental and therapeutic medicine.

[59]  W. Cho,et al.  Cancer and Aging - the Inflammatory Connection , 2017, Aging and disease.

[60]  S. Brandhorst,et al.  Protective effects of short-term dietary restriction in surgical stress and chemotherapy , 2017, Ageing Research Reviews.

[61]  M. Holz,et al.  The therapeutic potential of resveratrol: a review of clinical trials , 2017, npj Precision Oncology.

[62]  Danica Chen,et al.  Nutrient Sensing and the Oxidative Stress Response , 2017, Trends in Endocrinology & Metabolism.

[63]  C. O’Flanagan,et al.  When less may be more: calorie restriction and response to cancer therapy , 2017, BMC Medicine.

[64]  C. Isidoro,et al.  Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation , 2017, Neurochemistry International.

[65]  E. Laconi,et al.  Caloric restriction delays early phases of carcinogenesis via effects on the tissue microenvironment , 2017, Oncotarget.

[66]  S. Groshen,et al.  Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease , 2017, Science Translational Medicine.

[67]  Zhuo-wei Hu,et al.  Autophagy-inducing natural compounds: a treasure resource for developing therapeutics against tissue fibrosis , 2017, Journal of Asian natural products research.

[68]  A. Engelbrecht,et al.  Enhanced Therapeutic Efficacy in Cancer Patients by Short-term Fasting: The Autophagy Connection , 2016, Front. Oncol..

[69]  H. Fuchs,et al.  Cardioprotection and lifespan extension by the natural polyamine spermidine , 2016, Nature Medicine.

[70]  Carlo Follo,et al.  PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells , 2016, Oncotarget.

[71]  C. Isidoro,et al.  Resveratrol inhibits IL‐6‐induced ovarian cancer cell migration through epigenetic up‐regulation of autophagy , 2016, Molecular carcinogenesis.

[72]  Z. Gillespie,et al.  Better Living through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and Lifespan , 2016, Frontiers in Genetics.

[73]  G. Jena,et al.  Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: A comparative study with metformin. , 2016, Chemico-biological interactions.

[74]  F. Di Virgilio,et al.  Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. , 2016, Cancer Cell.

[75]  Yingmei Zhang,et al.  ATM mediates spermidine-induced mitophagy via PINK1 and Parkin regulation in human fibroblasts , 2016, Scientific Reports.

[76]  A. Russo,et al.  Dietary restriction: could it be considered as speed bump on tumor progression road? , 2016, Tumor Biology.

[77]  S. Sinha,et al.  Epigenetic targets in cancer and aging: dietary and therapeutic interventions , 2016, Expert opinion on therapeutic targets.

[78]  F. Rossi,et al.  Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA , 2015, Scientific Reports.

[79]  C. Busch,et al.  Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment , 2015, Nutrition Journal.

[80]  Xin-yang Wang,et al.  Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling , 2015, International journal of oncology.

[81]  Simon R. Goodyear,et al.  The effects of graded levels of calorie restriction: I. impact of short term calorie and protein restriction on body composition in the C57BL/6 mouse , 2015, Oncotarget.

[82]  D. Raggi,et al.  Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma , 2015, Therapeutic advances in urology.

[83]  L. Partridge,et al.  Promoting Health and Longevity through Diet: From Model Organisms to Humans , 2015, Cell.

[84]  G. Kroemer,et al.  Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers , 2014, Autophagy.

[85]  J. Ricci,et al.  Caloric restriction and cancer: molecular mechanisms and clinical implications. , 2014, Trends in molecular medicine.

[86]  S. Kaasa,et al.  Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[87]  C. López-Otín,et al.  Regulation of autophagy by cytosolic acetyl-coenzyme A. , 2014, Molecular cell.

[88]  P. Sykacek,et al.  A dual role for autophagy in a murine model of lung cancer , 2014, Nature Communications.

[89]  Hyun-Seok Kim,et al.  Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer , 2013, BMB reports.

[90]  E. Mercken,et al.  Metformin improves healthspan and lifespan in mice , 2013, Nature Communications.

[91]  P. Agostinis,et al.  Autophagy: shaping the tumor microenvironment and therapeutic response. , 2013, Trends in molecular medicine.

[92]  S. Shouman,et al.  Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells , 2013, Human & experimental toxicology.

[93]  L. Lashinger,et al.  Calorie restriction and cancer prevention: a mechanistic perspective , 2013, Cancer & metabolism.

[94]  D. C. D. da Costa,et al.  Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest , 2012, Journal of cellular biochemistry.

[95]  Jungil Choi,et al.  Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression. , 2011, Anticancer research.

[96]  Mark S. Sundrud,et al.  Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase , 2011, Nature chemical biology.

[97]  J. Auwerx,et al.  Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. , 2011, Cell metabolism.

[98]  Changhan Lee,et al.  Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients , 2011, Oncogene.

[99]  M. Sawyer,et al.  Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity , 2011, Current opinion in clinical nutrition and metabolic care.

[100]  S. Kulp,et al.  Energy restriction as an antitumor target. , 2010, Future oncology.

[101]  D. Klionsky,et al.  Eaten alive: a history of macroautophagy , 2010, Nature Cell Biology.

[102]  T. Tollefsbol,et al.  Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[103]  J. Kieswich,et al.  Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. , 2010, The Journal of endocrinology.

[104]  V. Longo,et al.  Calorie restriction and cancer prevention: metabolic and molecular mechanisms. , 2010, Trends in pharmacological sciences.

[105]  R. Garofalo,et al.  SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.

[106]  Frank Sinner,et al.  Induction of autophagy by spermidine promotes longevity , 2009, Nature Cell Biology.

[107]  T. Whiteside,et al.  Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin , 2009, PloS one.

[108]  Shailendra Giri,et al.  Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis , 2009, The Journal of Immunology.

[109]  Mark S. Sundrud,et al.  Halofuginone Inhibits TH17 Cell Differentiation by Activating the Amino Acid Starvation Response , 2009, Science.

[110]  D. Ingram,et al.  Optimal window of caloric restriction onset limits its beneficial impact on T‐cell senescence in primates , 2008, Aging cell.

[111]  Ajay Goel,et al.  Multi-targeted therapy by curcumin: how spicy is it? , 2008, Molecular nutrition & food research.

[112]  K. Griffith,et al.  Resveratrol inhibits glucose metabolism in human ovarian cancer cells. , 2007, Gynecologic oncology.

[113]  Irfan Rahman,et al.  Regulation of inflammation and redox signaling by dietary polyphenols. , 2006, Biochemical pharmacology.

[114]  T. Seyfried,et al.  Antiangiogenic and Proapoptotic Effects of Dietary Restriction on Experimental Mouse and Human Brain Tumors , 2004, Clinical Cancer Research.

[115]  T. Seyfried,et al.  Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model , 2002, British Journal of Cancer.

[116]  A. Hochberg,et al.  Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone. , 1999, Cancer research.

[117]  M. Pines,et al.  Halofuginone: a novel antifibrotic therapy. , 1998, General pharmacology.

[118]  R. Schilling Curcumin And Cancer , 2017 .

[119]  C. Smyl Ketogenic Diet and Cancer-a Perspective. , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[120]  S. Brandhorst,et al.  Fasting and Caloric Restriction in Cancer Prevention and Treatment. , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[121]  S. Perkins,et al.  Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. , 2010, Carcinogenesis.

[122]  H. Chung,et al.  The inflammation hypothesis of aging: molecular modulation by calorie restriction. , 2001, Annals of the New York Academy of Sciences.